IMA vs RMD · rev $9.2M vs P/E 29, $37.68B cap
ImageneBio, Inc. (IMA) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
RMD does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the IMA and RMD stock pages for the full models.
Not investment advice.